Chargement en cours...
Characterizing lymphocyte counts and infection rates with long-term teriflunomide treatment: Pooled analysis of clinical trials
BACKGROUND: In Phase 3 studies, teriflunomide reduced relapse rates and disability progression compared with placebo; however, decreases in lymphocyte counts were also observed. OBJECTIVE: To describe the effect of long-term teriflunomide treatment on lymphocyte counts and infection rates among pati...
Enregistré dans:
| Publié dans: | Mult Scler |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7412877/ https://ncbi.nlm.nih.gov/pubmed/31172849 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458519851981 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|